Triple-negative breast cancers (TNBC) are proof against standard-of-care chemotherapy and lack identified targetable driver gene alterations. Identification of novel drivers may help the invention of…
Triple-negative breast cancers (TNBC) are proof against standard-of-care chemotherapy and lack identified targetable driver gene alterations. Identification of novel drivers may help the invention of…